Skip To Main Content
Michael Wong on Muck Rack

Michael Wong

Houston
As seen in: Color Research & Application, Nature, Wiley, Wiley Online Library, National Geographic, MDPI, PNAS, South China Morning Post, Caltech, Mary Ann Liebert, Inc. and
@RiceCHBE Dept Chair and Prof; Tina and Sunit Patel Endowed Chair; Chemistry; @RiceCEVE; @RiceMSNE; @NEWTCenter @ChEnected @ACSCATLDivision @SouthwestCatSoc
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Michael

Contact Michael, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

綠茵場上的終極權力遊戲：解構 2026 世界盃，一場為 MAGA 量身打造的政治洗白大秀

|
By Michael Wong
| sportsv.net
2025年的夏天，當首屆改制後的 FIFA 世冠盃 (FIFA Club World Cup) 在美國新澤西的 MetLife Stadium 落下帷幕，我們見證的不僅是一場足球賽事的終結，更是一場政治操弄的極致展演。想像一下那個畫面：綠茵場上，Chelsea 剛剛在戰術博弈中擊垮了揮金如土的 PSG。然而，當鏡頭轉向頒獎台，真正的主角卻不是那些力竭的球員。FIFA 主席 Gianni Infantino 帶著他招牌式的諂媚微笑，極度識趣地退到陰影處；而鎂光燈的絕對中心，是繫著標誌性紅領帶的美國總統 Donald Trump。他大搖大擺地站在獎盃旁，與 Chelsea 隊長Reece James並肩，彷彿他才是策劃這場勝利的幕後主帥。這尷尬、突兀卻充滿龐大視覺暴力的畫面，像一記重拳砸在所有純粹足球迷的臉上。如果連一項原本旨在測試全球頂級球會戰術含金量的盃賽，都能被如此粗暴地政治收編，那麼即將到來的 2026 年美加墨世界盃，究竟會變成一場怎樣的政治狂歡？我們面對的，不再是單純的體育盛會，而是一台被精算過的國家級宣傳機器。...
Open in Who Shared Issue with article?

Mocertatug Rezetecan Shows High ORR in Ovarian and Endometrial Cancer

|
By Michael Wong, Kyle Doherty, Courtney Flaherty Verified
| Oncology Nursing News Verified
Managing platinum-resistant ovarian cancer (PROC) remains a significant hurdle in gynecologic oncology, but interim data from the BEHOLD-1 study (NCT06431594) offers a new reason for optimism. Presented at the 2026 SGO Annual Meeting, the B7-H4–targeted ADC mocertatug rezetecan (GSK5733584) demonstrated encouraging clinical activity and a manageable safety profile in patients with advanced ovarian and endometrial cancers.
Open in Who Shared Issue with article?

Mirvetuximab Soravtansine Real-World Ovarian Cancer Data Matches MIRASOL

|
By Michael Wong, Courtney Flaherty Verified, Kyle Doherty
| Oncology Nursing News Verified
Recent real-world data confirms that Elahere (mirvetuximab soravtansine-gynx) survival outcomes for recurrent ovarian cancer align with pivotal MIRASOL trial (NCT04209855) findings. While effective, a retrospective analysis presented at SGO 2026 highlights significant toxicity risks and lower life expectancy for patients with poor performance status (ECOG PS).
Open in Who Shared Issue with article?
See all 53 licensed articles (60 Total)